OBN Management - OBN: Comprehensive Support for UK Bioscience Business via Networking, Partnering & Purchasing

OBN Management

OBN Management Structure including Board of Directors and Advisory Board

Strategic and Operational Management is led by Dr. Jon Rees, CEO, while OBN is governed by a balanced Board of Directors, and is guided by its outstanding Advisory Board which includes a high level of industry representation. A number of OBN's Advisory Board members have been on-board since its foundation. OBN is owned and operated by Oxfordshire Bioscience Network Ltd, a not-for-profit company. Read more about our Terms of Reference.

Board of Directors*

Chaired by Dr. Steven Lee

Rod Cook BSc FCIPD, Biotech Personnel

Prof Chris Hawes, Director of Research, School of Life Sciences, Oxford Brookes University

David Laskow-Pooley, MD, Pharmafor

Dr. Steven Lee, CEO, Summit plc

Dr. Jon Rees, CEO, OBN

Prof. Russell Smith, CEO, Business Boffins

*Directors serve in an individual capacity

Advisory Board

Chaired by Dr. Steven Lee

Dr. Mark R Ashton, Executive VP for Business Development, Evotec (UK) Ltd

Patrick Baddeley, Corporate Finance Partner, Manches LLP

Phil Boyd, CFO, Syntaxin

Rod Cook BSc FCIPD, Biotech Personnel

Scott Cuthill, PhD, Associate Director Business Development, Chroma Therapeutics

Paul Drohan, SVP Commonwealth and Ireland for Genzyme Therapeutics

Allen Hakimi is MD of Technomark Life Sciences

Prof Chris Hawes, Director of Research, School of Life Sciences, Oxford Brookes University

David Laskow-Pooley, MD, Pharmafor

Dr. Steven Lee, CEO, Summit plc

Dr. Linda Naylor, Head of Technology Transfer, Isis Innovation

Bryan Morton, President and Chief Executive, EUSA Pharma

Dr. Jon Rees, CEO, OBN

Les Russell, CEO, OrganOx

Bruce Savage, CEO, GFC Diagnostics

Alison Saunders, CEO, Alchemy Healthcare

Stewart Sharpe, Senior Director, Strategic Brand Management, OSI Pharmaceuticals UK

Prof. Russell Smith, CEO, Business Boffins

Sue Staunton, Partner, James Cowper

Dr. Sally Waterman, COO, PolyTherics

Mike Wort, Managing Director, De Facto Communications